Walleye Capital LLC Sells 4,244 Shares of Teleflex Incorporated (NYSE:TFX)

Walleye Capital LLC trimmed its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 76.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,287 shares of the medical technology company's stock after selling 4,244 shares during the quarter. Walleye Capital LLC's holdings in Teleflex were worth $318,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Cooke & Bieler LP increased its position in shares of Teleflex by 23.3% in the second quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company's stock worth $191,989,000 after purchasing an additional 172,335 shares during the period. TD Asset Management Inc raised its position in shares of Teleflex by 12.0% in the 2nd quarter. TD Asset Management Inc now owns 456,081 shares of the medical technology company's stock valued at $95,928,000 after buying an additional 48,832 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in shares of Teleflex by 0.4% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company's stock worth $105,749,000 after acquiring an additional 1,884 shares during the period. Bank of New York Mellon Corp boosted its position in shares of Teleflex by 6.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 425,647 shares of the medical technology company's stock worth $89,526,000 after acquiring an additional 26,325 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in Teleflex by 4.2% in the second quarter. Dimensional Fund Advisors LP now owns 398,175 shares of the medical technology company's stock valued at $83,741,000 after acquiring an additional 15,992 shares during the last quarter. Institutional investors own 95.62% of the company's stock.

Teleflex Trading Down 0.3 %

TFX traded down $0.52 during trading on Tuesday, reaching $186.52. 324,513 shares of the company's stock were exchanged, compared to its average volume of 383,487. The firm has a fifty day moving average price of $212.96 and a two-hundred day moving average price of $221.34. The stock has a market capitalization of $8.66 billion, a PE ratio of 37.08, a price-to-earnings-growth ratio of 1.89 and a beta of 1.16. Teleflex Incorporated has a one year low of $183.90 and a one year high of $257.85. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating analysts' consensus estimates of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $764.40 million during the quarter, compared to the consensus estimate of $768.68 million. During the same period in the prior year, the business posted $3.64 earnings per share. Teleflex's quarterly revenue was up 2.4% on a year-over-year basis. As a group, equities research analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.73%. The ex-dividend date of this dividend is Friday, November 15th. Teleflex's payout ratio is presently 27.04%.

Analyst Ratings Changes

TFX has been the topic of a number of research analyst reports. Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a report on Friday, November 1st. Mizuho decreased their target price on Teleflex from $275.00 to $250.00 and set a "neutral" rating on the stock in a research report on Friday, November 1st. Truist Financial reissued a "hold" rating and set a $227.00 target price (down previously from $255.00) on shares of Teleflex in a research note on Monday, November 4th. StockNews.com upgraded shares of Teleflex from a "hold" rating to a "buy" rating in a research note on Thursday, November 28th. Finally, Royal Bank of Canada lowered their price objective on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating for the company in a research report on Friday, November 1st. Three research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, Teleflex presently has a consensus rating of "Moderate Buy" and a consensus price target of $259.00.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.